For Immediate Release
Media Contact: Bob Cooper
Date: July 18, 2005
Idahoans to Receive More Than $108,000 in Refunds for Purchase of Prescription Heart Medication
(Boise) – Attorney General Lawrence Wasden announced today that 343 Idahoans who were overcharged for the heart medication, Cardizem CD, and its generic equivalent, will receive more than $108,000 in refunds. The refunds are the result of a multi-state antitrust settlement announced January 27, 2003.
“Idahoans who purchased Cardizem CD can expect to receive an average refund of $314,” Wasden said. “The checks will begin to be mailed from the court-appointed administrator this week.”
The State of Idaho will receive more than $130,000 to recover damages incurred by the state, including attorneys fees, and costs and interest earned while the settlement was pending.
The distribution is the result of a 2003 lawsuit filed by Idaho and 28 other states against two pharmaceutical companies, Aventis Pharmaceuticals Inc. and Andrx Corporation. The lawsuit alleged that in July 1998, Hoechst, a pharmaceutical company acquired by Aventis in 2000, paid Andrx to withhold marketing of a generic version of Cardizem CD. The delay in the availability of the generic form of Cardizem CD meant that consumers, medical insurance companies and the State of Idaho had to purchase the higher priced brand name version of the drug for at least a year.
Additional details concerning the settlement are available via the Attorney General’s website.
- End -
NOTE TO READERS - This settlement information has expired and is no longer available.